NCT05572879

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

A Phase III, Randomized, Observer-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate Immunogenicity and Safety of a Preventive COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 2,600 (actual)
• Sponsor: EuBiologics Co.,Ltd · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is a phase III, randomized, observer-blind, active-controlled, parallel group, multi-center study to compare the immunogenicity and safety of a preventive COVID-19 vaccine EuCorVac-19 to ChAdOx1 in healthy adults aged 18 years and older

Conditions

• COVID-19

Interventions

Type	Name	Description
BIOLOGICAL	EuCorVac-19	COVID-19 vaccine
BIOLOGICAL	ChAdOx1 nCoV-19	COVID-19 vaccine

Timeline

• Start date: 2022-10-01
• Primary completion: 2023-06-23
• Completion: 2024-02-09
• First posted: 2022-10-10
• Last updated: 2024-06-17

Locations

1 site across 1 country: Philippines